StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Intercept (ICPT): In this Case, the Black Box Warning is a Positive - Baird
February 1, 2018 10:13 AM
Baird analyst Brian Skorney said the Black Box warning on Intercept Pharmaceuticals' (NASDAQ: ICPT) Ocaliva is a positive. The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Intercept Pharma (ICPT) Confirms U.S. Prescribing Information for Ocaliva to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis
February 1, 2018 9:47 AM
Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis
February 1, 2018 9:46 AM
RBC Capital on Intercept Pharma (ICPT): Benign Label Update Removes Key Overhang, Should Set Stage for Ocaliva Growth
February 1, 2018 9:42 AM
Pre-Open Movers 02/01: (OPGN) (AFMD) (ICPT) Higher; (EGOV) (ONCS) (UPS) Lower (more...)
February 1, 2018 9:31 AM
FDA Adds Boxed Warning for Correct Dosing of Intercept Pharma's (ICPT) Ocaliva
February 1, 2018 9:05 AM
